Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Otolaryngology (ENT)

Understanding Your Diagnosis and Validating Your Experience

At a Glance

Relapsing polychondritis is a rare autoimmune disease that attacks cartilage and can affect the ears, nose, joints, airways, eyes, heart valves, aorta, and inner ear. Diagnosis often takes time, and symptoms may flare, persist, or occur in a single major episode.

Receiving a diagnosis of relapsing polychondritis (RP) often brings a complicated mix of emotions. For many, there is a profound sense of relief in finally having a name for symptoms that may have been dismissed or misunderstood for years [1]. At the same time, it is natural to feel overwhelmed by the rarity and unpredictability of the condition. You are not alone in this journey, even though the road to get here may have felt isolating.

This guide is an educational resource. RP is rare, and much of the medical evidence comes from observational studies rather than large clinical trials. Always discuss your specific situation with your medical team, and remember that emergency symptoms always override routine appointment plans.

Validating Your Diagnostic Journey

Relapsing polychondritis is exceptionally rare. A UK population study from 1990-2012 found an incidence rate (the number of new cases diagnosed each year) of only 0.71 per million people [2]. Because the disease is so uncommon, many primary care doctors and even some specialists may only see one case in their entire career.

This rarity often leads to what patients call a “diagnostic odyssey.” Research shows that the median time from the first symptom to a formal diagnosis is approximately 1.9 years [2]. During this time, more than half of patients visit at least three different doctors or seek help in emergency departments before receiving the correct answer [3][4]. If you felt like you had to fight for your diagnosis or were misdiagnosed along the way, your experience is unfortunately common among those with RP [5].

What is Relapsing Polychondritis?

RP is an autoimmune condition, which means your immune system—which is supposed to protect you from germs—mistakenly attacks your body’s own healthy tissues [6]. Specifically, it targets cartilage, the tough but flexible tissue that provides structure to various parts of your body.

While the disease is most famous for affecting the “visible” cartilage, it is a systemic (body-wide) condition that can involve several areas:

  • The Ears and Nose: This is the most common sign, appearing in about 80% of patients. It often involves painful swelling, redness, and a “floppy” or “saddle-nose” deformity if the cartilage breaks down [7][8].
  • The Joints: Many people experience polyarthritis (inflammation in multiple joints), which can cause pain and stiffness similar to other types of arthritis [7].
  • The Airways: Cartilage also holds your windpipe (trachea) and voice box (larynx) open. Inflammation here can affect your breathing or change the sound of your voice [9][10].
  • Other Tissues: Because the body is attacking components like collagen, RP can also affect the eyes (causing redness or pain), the heart valves, the aorta, and the inner ear (affecting hearing or balance) [11][12].

Understanding Your Disease Pattern

RP does not look the same for everyone. Doctors often describe the disease course using three main patterns, though your experience may shift over time [6][13]:

  1. Relapsing-Remitting: This is the most common pattern. You may experience “flares”—periods where symptoms are active and intense—followed by “remissions,” where the inflammation quiets down and you feel much better [14].
  2. Persistently Active: In this pattern, the disease remains at a low-to-moderate level of activity most of the time, requiring constant management to keep inflammation in check [15].
  3. Monophasic: Though less common, some individuals experience a single major episode of inflammation that, once treated, does not return for a very long period [13].

The Emotional Impact

Living with a rare disease requires significant mental and emotional energy. Studies have found that RP can deeply affect personal relationships, work capacity, and daily activities [1]. Fatigue is one of the most frequently reported challenges, and it can sometimes be more frustrating than the physical pain because it is “invisible” to others [16].

It is common to feel a sense of “social invalidation”—the feeling that friends, family, or even some doctors don’t fully grasp the severity of what you are going through because they cannot see the internal inflammation [1]. Recognizing that these feelings are a documented part of the RP experience can be the first step in building a support system that truly understands your needs.

Common questions in this guide

Why does it sometimes take a long time to diagnose relapsing polychondritis?
Relapsing polychondritis is rare, so many clinicians have little experience recognizing it, and its symptoms can involve different parts of the body. In studies of this condition, the median time from the first symptom to diagnosis was about 1.9 years, and more than half of patients saw at least three doctors or visited an emergency department.
Which parts of the body can relapsing polychondritis affect?
It most often affects the cartilage of the ears and nose, but it can also involve the joints, windpipe, voice box, eyes, heart valves, aorta, and inner ear. These areas can cause symptoms such as swelling, joint pain, breathing or voice changes, eye pain, or hearing and balance problems.
What patterns can relapsing polychondritis follow?
Some people have relapsing-remitting disease, with flares followed by quieter periods. Others have persistent low-to-moderate activity, or a single major episode that does not return for a long time; the pattern can change over time.
How can relapsing polychondritis affect everyday life?
RP can cause fatigue and can affect work, relationships, and daily activities, even when the inflammation is not obvious to other people. Feeling that others do not understand the illness is common, and a supportive personal and care network can help reduce isolation.
Which specialists may be involved in my relapsing polychondritis care?
The right care team depends on which tissues are affected. An ear, nose, and throat specialist may help with ear, nose, throat, or airway concerns, while an ophthalmologist can evaluate eye symptoms; your treating clinicians can advise which specialists you need.
What is the RPDAI, and how might it be used?
The Relapsing Polychondritis Disease Activity Index, or RPDAI, is a clinical scoring tool your doctor may use to describe how active the disease is. Asking for your current score can help you understand how your care team plans to track changes over time.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many other patients with relapsing polychondritis have you or your practice treated?
  2. 2.Given my specific symptoms, which 'phenotype' (pattern of observable traits) of the disease do I currently seem to have?
  3. 3.What is my current Relapsing Polychondritis Disease Activity Index (RPDAI) score, and how will we use this clinical tool to track it over time?
  4. 4.Should I be screened for associated conditions like VEXAS syndrome or myelodysplastic syndrome based on my blood work?
  5. 5.Which specific specialists (like an ENT or ophthalmologist) should be on my core care team right now?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument.

    Mertz P, Sander O, Faria R, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 41808205
  2. 2

    Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study.

    Hazra N, Dregan A, Charlton J, et al.

    Rheumatology (Oxford, England) 2015; (54(12)):2181-7 doi:10.1093/rheumatology/kev240.

    PMID: 26187053
  3. 3

    Patient Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis.

    Ferrada MA, Grayson PC, Banerjee S, et al.

    Arthritis care & research 2018; (70(8)):1124-1131 doi:10.1002/acr.23492.

    PMID: 29245173
  4. 4

    Patient-perceived Burden of Disease in Pediatric Relapsing Polychondritis.

    Rimland CA, Ferrada MA, Sinaii N, et al.

    The Journal of rheumatology 2019; (46(12)):1627-1633 doi:10.3899/jrheum.181456.

    PMID: 31043550
  5. 5

    Diagnosing relapsing polychondritis remains a common challenge: experience from a Chinese retrospective cohort.

    Zhang L, Wu TG, He YJ, et al.

    Clinical rheumatology 2020; (39(7)):2179-2184 doi:10.1007/s10067-019-04852-3.

    PMID: 32036586
  6. 6

    French practical guidelines for the diagnosis and management of relapsing polychondritis.

    Arnaud L, Costedoat-Chalumeau N, Mathian A, et al.

    La Revue de medecine interne 2023; (44(6)):282-294 doi:10.1016/j.revmed.2023.05.005.

    PMID: 37236870
  7. 7

    [Treatment of a patient with relapsing polychondritis: Case report].

    Reznik EV, Golubev YY, Yurtayeva NV, et al.

    Terapevticheskii arkhiv 2025; (97(5)):471-474 doi:10.26442/00403660.2025.05.203212.

    PMID: 40561492
  8. 8

    Relapsing Polychondritis: An Updated Review.

    Borgia F, Giuffrida R, Guarneri F, Cannavò SP

    Biomedicines 2018; (6(3)) doi:10.3390/biomedicines6030084.

    PMID: 30072598
  9. 9

    Tracheobronchial involvement of relapsing polychondritis.

    de Montmollin N, Dusser D, Lorut C, et al.

    Autoimmunity reviews 2019; (18(9)):102353 doi:10.1016/j.autrev.2019.102353.

    PMID: 31323366
  10. 10

    Characteristics and Clinical Outcomes of 295 Patients With Relapsing Polychondritis.

    Chen N, Zheng Y

    The Journal of rheumatology 2021; (48(12)):1876-1882 doi:10.3899/jrheum.210062.

    PMID: 34334365
  11. 11

    The ocular manifestations of relapsing polychondritis.

    Gallagher K, Al-Janabi A, Wang A

    International ophthalmology 2023; (43(8)):2633-2641 doi:10.1007/s10792-023-02662-w.

    PMID: 36856986
  12. 12

    Relapsing polychondritis, a rare cause of valvulopathy: a review of the medical literature.

    Bahena-López E, Loya-Centurión J

    Archivos de cardiologia de Mexico 2020; (90(2)):189-192 doi:10.24875/ACM.19000245.

    PMID: 32459198
  13. 13

    [Tracheobronchial involvement in relapsing polychondritis and differential diagnoses].

    Grandière L, Gille T, Brillet PY, et al.

    Revue des maladies respiratoires 2024; (41(6)):421-438 doi:10.1016/j.rmr.2024.03.009.

    PMID: 38762394
  14. 14

    A multicenter study of long-term outcomes of relapsing polychondritis in Iran.

    Jafarpour M, Saberivand M, Saemi M, et al.

    Scientific reports 2024; (14(1)):16486 doi:10.1038/s41598-024-67530-8.

    PMID: 39020004
  15. 15

    Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis.

    Sharma A, Kumar R, Mb A, et al.

    Rheumatology (Oxford, England) 2020; (59(1)):99-106 doi:10.1093/rheumatology/kez243.

    PMID: 31236569
  16. 16

    Discordance in patient and physician global assessment in relapsing polychondritis.

    Rose E, Ferrada MA, Quinn KA, et al.

    Rheumatology (Oxford, England) 2022; (61(5)):2025-2033 doi:10.1093/rheumatology/keab587.

    PMID: 34559216

This page is for education about relapsing polychondritis and does not replace medical advice. Discuss your symptoms, disease activity, and specialist needs with your medical team, and seek urgent care for emergency symptoms.

Get notified when new evidence is published on Relapsing polychondritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.